The latest medical insurance price of Everolimus in 2023

Everolimus (Everolimus) is a drug that belongs to the category of immunosuppressants and is also classified as a targeted therapy drug. Everolimus interferes with intracellular signaling pathways by inhibiting the activity of the protein mTOR (mammalian target of rapamycin), thereby regulating cell growth, proliferation and immune responses. It plays an important role in immunosuppression, anticancer therapy, and drug coatings for coronary stents.

Everolimus has been approved for marketing in my country, and has been included in the national medical insurance. The price is about 4000~5000 yuan. It takes about 2 boxes of everolimus per month. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are mainly Indian generic drugs, the price is around 700~1,500yuan, and the ingredients of the drugs are basically the same as those in China.

Everolimus is often used as immunosuppressive treatment after organ transplantation to help reduce the patient's immune system's rejection of allogeneic organs and improve the survival rate of transplanted organs. Everolimus is also used in the treatment of some cancers, especially renal cell carcinoma and neuroendocrine tumors, to inhibit the progression of cancer by interfering with the proliferation and growth signaling pathways of cancer cells. Everolimus is also used in drug-coated stents in the treatment of coronary artery stenosis to reduce the risk of in-stent re-stenosis.

The use of everolimus may cause a series of side effects, including the risk of infection related to immunosuppression, oral ulcers, skin problems, impaired kidney function, etc. While taking everolimus, patients need to be monitored closely and follow their doctor's advice and instructions.